Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helped a patient with alopecia areata regrow hair.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

pbn-STAC effectively finds strategies for cellular reprogramming using deep reinforcement learning.

Thymosin β4 helps with healing, inflammation, and organ protection.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

The HIF-2α/ARNT complex is important for hair follicle development by controlling cell growth.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

A protein called GIS3 is important for the growth of root hairs in Arabidopsis by controlling two genes with the help of certain growth signals.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Baricitinib can cause excessive hair growth.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

CCC1 is essential for pH balance and normal cell function in plants.

VILLIN4 helps root hair growth by organizing actin with calcium.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

The hydrogel helps reduce scarring and improve wound healing by releasing salvianolic acid B in acidic conditions.

COX2 and ATP synthase control the size of hedgehog spines.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Finding functions for unknown GPCRs is hard but key for making new drugs.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Reduced plakoglobin and steroid abuse increase the risk of heart rhythm issues.